InvestorsHub Logo
Followers 0
Posts 140
Boards Moderated 0
Alias Born 04/28/2010

Re: microcapbiotech post# 29676

Monday, 03/02/2020 5:40:52 PM

Monday, March 02, 2020 5:40:52 PM

Post# of 34626
Nothing in the PR says that "the first Marker-sponsored clinical trial this year investigating our novel MultiTAA cell therapy." will be Pancreatic based.

Having said that; if they are going after PC then they should definitely optimize the antigen mix, IMO. (I'm not a Dr. or researcher, so take that with a huge grain of salt).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News